Quick Takeaways
- Enavate Sciences GP, LLC filed SCHEDULE 13D for SIONNA THERAPEUTICS, INC. Common Stock, $0.001 par value per share (SION).
- Disclosed ownership: 5.6%.
- Date of event: 10 Feb 2025.
Enavate Sciences GP, LLC - 10 Feb 2025 SCHEDULE 13D Report for SIONNA THERAPEUTICS, INC. Common Stock, $0.001 par value per share (SION)
- Filing Manager
- Enavate Sciences GP, LLC
- Reporting Manager
- Enavate Sciences GP, LLC
- Symbol
- SION
- Shares outstanding
- 44,250,536 shares
- Disclosed Ownership
- 2,478,030 shares
- Ownership
- 5.6%
- Form type
- SCHEDULE 13D
- Filing time
- 18 Feb 2025, 16:22:39 UTC
- Date of event
- 10 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Enavate Sciences GP, LLC disclosed 5.6% ownership in SIONNA THERAPEUTICS, INC. Common Stock, $0.001 par value per share (SION) on 10 Feb 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 18 Feb 2025, 16:22.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Enavate Sciences GP, LLC | 5.6% | 2,478,030 | 0 | 2,478,030 | /s/ James P. Boylan | By James P. Boylan, Manager | 0001953107 |
| Sionna Aggregator, LP | 5.6% | 2,478,030 | 0 | 2,478,030 | /s/ James P. Boylan | By: Enavate Sciences GP, LLC, its General Partner, By James P. Boylan, Manager | 0002055981 |